Form 8-K - Current report:
SEC Accession No. 0001213900-24-109825
Filing Date
2024-12-17
Accepted
2024-12-17 16:55:12
Documents
13
Period of Report
2024-12-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0225149-8k_oramed.htm   iXBRL 8-K 26670
  Complete submission text file 0001213900-24-109825.txt   200299

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ormp-20241213.xsd EX-101.SCH 3009
3 XBRL LABEL FILE ormp-20241213_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ormp-20241213_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0225149-8k_oramed_htm.xml XML 3688
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 241556427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)